Mesuron

Mesuron is a private U.S. medical device company based in Latham, New York focused on cardiac diagnostics using superconducting quantum interference device (SQUID)-based magnetocardiography. Its lead product, the Avalon-H90, is a non-contact, non-invasive heart screening system designed to analyze cardiac magnetic signals and help identify myocardial abnormalities in settings such as emergency departments and catheterization labs. The company positions the technology as a rapid triage and screening tool for acute chest pain and related cardiac conditions without radiation, contrast agents, or direct patient contact. Mesuron has collaborated with Mayo Clinic, which entered into a know-how collaboration and stock purchase agreement with the company to help refine analytic software and protocols for the Avalon-H90. Overall, Mesuron appears to be a small, privately held healthcare technology company centered on advanced cardiac diagnostic instrumentation rather than therapeutics.